Alzamend Neuro (ALZN) Stock Chart & Stock Price History $2.96 -0.04 (-1.17%) Closing price 07/3/2025 03:25 PM EasternExtended Trading$2.96 0.00 (0.00%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alzamend Neuro Stock Price Performance The Alzamend Neuro (ALZN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 91.57%, with a year-to-date return of -71.60%. In the past month, the stock has decreased 18.09%, reflecting recent market activity. As of the latest close, Alzamend Neuro traded at $2.97 with a market cap of $2.37 million and volume of 89,378 shares. Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.54%1 Month Performance-18.09%3 Month Performance-66.48%Year-To-Date Performance-71.60%1 Year Performance-91.57% ALZN Stock Chart for Sunday, July, 6, 2025 ALZN Chart by TradingView Alzamend Neuro Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$2.97$2.97$3.04$2.9089,378 shs$2.38 million07/03/2025$3.00$2.97-1.17%$3.04$2.9089,378 shs$2.37 million07/02/2025$2.92$3.00+2.74%$3.05$2.87393,042 shs$2.40 million07/01/2025$2.91$2.92+0.34%$2.92$2.81111,252 shs$2.34 million06/30/2025$2.90$2.91+0.34%$2.97$2.84196,813 shs$2.33 million06/27/2025$2.92$2.90-0.68%$2.96$2.82131,052 shs$2.32 million06/26/2025$2.90$2.92+0.69%$2.95$2.75289,148 shs$2.34 million06/25/2025$2.93$2.90-1.02%$2.98$2.80231,041 shs$2.32 million06/24/2025$2.95$2.93-0.68%$2.98$2.79317,242 shs$2.34 million06/23/2025$3.04$2.95-2.96%$3.06$2.86253,368 shs$2.36 million Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$3.02$3.04+0.66%$3.06$2.93168,566 shs$2.44 million06/19/2025$3.02$3.02$3.07$2.94291,284 shs$2.42 million06/18/2025$2.97$3.02+1.68%$3.07$2.94291,284 shs$2.42 million06/17/2025$3.09$2.97-3.88%$3.06$2.90217,259 shs$2.38 million06/16/2025$3.24$3.09-4.63%$3.27$2.98426,983 shs$2.48 million06/13/2025$3.19$3.24+1.57%$3.43$3.17742,830 shs$2.60 million06/12/2025$3.34$3.19-4.49%$3.35$3.052.45 million shs$2.56 million06/11/2025$3.32$3.34+0.60%$3.40$3.29215,123 shs$2.68 million06/10/2025$3.45$3.32-3.77%$3.44$3.28143,226 shs$2.66 million06/09/2025$3.62$3.45-4.70%$3.64$3.37196,665 shs$2.76 million06/06/2025$3.72$3.62-2.69%$3.76$3.53229,399 shs$2.90 million06/05/2025$3.97$3.72-6.30%$4.00$3.68303,315 shs$2.98 million Related Companies GT Biopharma Stock Chart AEON Biopharma Stock Chart Jade Biosciences Stock Chart Kiora Pharmaceuticals Stock Chart Chromocell Therapeutics Stock Chart Turnstone Biologics Stock Chart Cellectar Biosciences Stock Chart Traws Pharma Stock Chart ObsEva Stock Chart Biomerica Stock Chart Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALZN) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALZN Stock Alerts